Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

New Phase 3 Data Shows Vedolizumab Met Primary Endpoint

americanpharmaceuticalreviewJuly 24, 2018

Tag: New Phase 3 Data , vedolizumab , Primary Endpoint

PharmaSources Customer Service